Get the Stockscreener App
123.54
24.78%
24.53
Pre-market:
122.81
-0.73
-0.59%
Illumina Inc stock is traded at $123.54, with a volume of 6.79M.
It is up +24.78% in the last 24 hours and up +30.08% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$99.01
Open:
$106.91
24h Volume:
6.79M
Relative Volume:
3.95
Market Cap:
$18.99B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
15.65
EPS:
7.8957
Net Cash Flow:
$943.00M
1W Performance:
+23.40%
1M Performance:
+30.08%
6M Performance:
+59.20%
1Y Performance:
-14.29%
1-Day Range:
$106.12
$123.93
1-Week Range:
$94.00
$123.93
52-Week Range:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
123.54 | 15.22B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
Genome (DNA) Sequencing Market Projections 2025-2032: Key - openPR.com
Envestnet Asset Management Inc. Sells 8,180 Shares of Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock draw ESG focused funds2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Combining machine learning predictions for Illumina Inc.July 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
Illumina (ILMN) Soars 23.4% on Earnings Beat - Insider Monkey
Developing predictive dashboards with Illumina Inc. data2025 Analyst Calls & Real-Time Buy Zone Alerts - newser.com
Will Illumina Inc. stock benefit from automationJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
Can Illumina Inc. (ILU) stock surprise with quarterly resultsGap Down & Weekly Return Optimization Plans - newser.com
Why Illumina Inc. (ILU) stock benefits from AI revolutionTrade Volume Summary & Long-Term Growth Portfolio Plans - newser.com
Why Illumina Inc. stock is considered a top pickGap Down & Advanced Swing Trade Entry Alerts - newser.com
Momentum divergence signals in Illumina Inc. chartDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
Will Illumina Inc. stock remain a Wall Street favoriteWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com
What moving averages say about Illumina Inc.Gold Moves & AI Enhanced Trading Signals - newser.com
Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio?Teradyne (NASDAQ:TER), Guardant Health (NASDAQ:GH), C.H. Robinson Worldwide (NASDAQ:CHRW), Credo Techn - Benzinga
Should I buy Illumina Inc. (ILU) stock before earnings seasonEntry Point & High Return Trade Guides - newser.com
What momentum indicators show for Illumina Inc. stockPortfolio Risk Report & Safe Swing Trade Setup Alerts - newser.com
Jennison Associates LLC Lowers Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stake Raised by Wealthfront Advisers LLC - MarketBeat
Oppenheimer Asset Management Inc. Has $965,000 Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock test record highs in 2025Weekly Market Outlook & Target Return Focused Stock Picks - newser.com
Illumina, Inc. (NASDAQ:ILMN) Q3 2025 Earnings Call Transcript - Insider Monkey
Illumina outlines path to high single-digit revenue growth and 20% margins by 2027 amid NovaSeq X acceleration - MSN
Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Illumina (ILMN) Jumps 24.8% on Earnings Beat - MSN
JPMorgan Chase & Co. Increases Illumina (NASDAQ:ILMN) Price Target to $105.00 - MarketBeat
Illumina (NASDAQ:ILMN) Shares Gap Up After Earnings Beat - MarketBeat
Illumina (NASDAQ:ILMN) Given New $142.00 Price Target at Evercore ISI - MarketBeat
Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Is Illumina Inc. stock safe for conservative investorsPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
4,386 Shares in Illumina, Inc. $ILMN Acquired by Earned Wealth Advisors LLC - MarketBeat
Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance
Illumina, Inc. $ILMN Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Keybank National Association OH Decreases Position in Illumina, Inc. $ILMN - MarketBeat
Y Intercept Hong Kong Ltd Has $2.41 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Analyzing Illumina Inc. with risk reward ratio chartsJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo! Finance Canada
Illumina (NASDAQ:ILMN) Issues Earnings Results - MarketBeat
Illumina Inc. (ILMN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Illumina’s Strategic Moves Propel Share Price - timothysykes.com
Barclays Raises Price Target for Illumina (ILMN) to $100 | ILMN Stock News - GuruFocus
Illumina (NASDAQ:ILMN) Releases FY 2025 Earnings Guidance - MarketBeat
Illumina Stock Soaring – What’s Next? - StocksToTrade
Illumina, Inc. (ILMN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Illumina Inc. Stock Advances 24.8%, Outperforms Peers - 富途牛牛
U.S. Indexes Closed Up Friday; Illumina Topped Leaders - Barron's
Illumina Stock Springs Back: Investment Alert? - timothysykes.com
JP Morgan Adjusts Price Target for Illumina (ILMN) While Maintai - GuruFocus
Illumina Inc reports results for the quarter ended September 30Earnings Summary - TradingView
China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030 - GlobeNewswire Inc.
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - MarketScreener
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):